National

Goods of Chinese origin to be released by Customs dept

TE Raja Simha Chennai | Updated on June 24, 2020 Published on June 24, 2020

Except for a few with ‘specific’ intelligence

Goods of Chinese origin have been ordered to be released by the Customs department except for a few with ‘specific’ intelligence. This comes after an intensified vigilance from Monday night on all Chinese cargo that has come to Chennai port and airport, based on ‘suspicion,’ said industry sources.

Customs officials were tight-lipped and declined to give any information on the search and what the suspicion was all about.

S Nataraja, President of Chennai Brokers Association, said that its members can approach custodian (port, airport or container freight station) for delivery of goods for which ‘out of charge’ order — issued by the Customs offer to clear the goods after payment of duty — had already been granted.

Direct Port Delivery containers that are granted OOC are being released by the port/terminals from Tuesday night. The association’s members are involved in clearing of goods.

Further, Bills of Entry (B/Es) filed before June 24 and pending for OOC are being redirected to groups for Customs examination and all air cargo Customs goods are released on completion of Customs examination. B/Es filed on or after June 24 will not have any issue and will be cleared as per the system guidelines, he said.

Chinese cargo is treated on par with any other country of origin cargo. There is no special treatment except on specific intelligence items that are undisclosed, he said. Nearly 30 per cent of cargo, mainly medical and electronic items, handled at Chennai originates from China, he added.

Published on June 24, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
Udupi administration asks pvt hospitals to be ready to treat Covid patients